Analyzing cancer-related changes in DNA and chromatin
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
['FUNDING_OTHER'] · VAN ANDEL RESEARCH INSTITUTE · NIH-10911854
This study is looking at how changes in our DNA can influence cancer and how well treatments work, with the goal of helping patients get better tests and more personalized care based on these findings.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VAN ANDEL RESEARCH INSTITUTE (nih funded) |
| Locations | 1 site (GRAND RAPIDS, UNITED STATES) |
| Trial ID | NIH-10911854 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding how epigenetic changes in DNA and chromatin contribute to cancer development and treatment outcomes. By analyzing large datasets of cancer genomic information, the project aims to identify specific epigenetic alterations that can affect cancer detection, classification, and resistance to therapies. Patients may benefit from improved diagnostic tools and personalized treatment strategies based on these findings. The research employs advanced bioinformatics techniques to interpret complex genomic data.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with various types of cancer who are interested in understanding the genetic and epigenetic factors influencing their disease.
Not a fit: Patients with non-cancerous conditions or those not interested in genetic analysis may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer diagnoses and tailored therapies for patients.
How similar studies have performed: Previous research has shown promising results in utilizing epigenomic profiling for cancer detection and treatment, indicating that this approach has potential for significant advancements.
Where this research is happening
GRAND RAPIDS, UNITED STATES
- VAN ANDEL RESEARCH INSTITUTE — GRAND RAPIDS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LAIRD, PETER W — VAN ANDEL RESEARCH INSTITUTE
- Study coordinator: LAIRD, PETER W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.